CNCR vs. XHE

Last updated Jun 24, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and XHE (SPDR S&P Health Care Equipment ETF) are both Health & Biotech Equities funds - CNCR tracks the Loncar Cancer Immunotherapy Index while XHE tracks the S&P Health Care Equipment Select Industry Index. Both are passively managed. CNCR charges 0.79%/yr vs 0.35%/yr for XHE.

Performance

CNCR vs. XHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and SPDR S&P Health Care Equipment ETF (XHE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

XHE

• 1D: 1.19%
• 1M: 0.26%
• YTD: -7.82%
• 6M: -9.00%
• 1Y: 2.70%
• 3Y*: -5.45%
• 5Y*: -8.83%
• 10Y*: 6.15%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. XHE - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
XHE SPDR S&P Health Care Equipment ETF	-3.37%

CNCR vs. XHE - Sectors Allocation Comparison

Sectors	CNCR	XHE
Healthcare	96.6%	98.2%
Financial Services	3.3%	1.8%
Basic Materials	-	-
Communication Services	-	1.4%
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	1.7%
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CNCR vs. XHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

XHE

XHE Risk / Return Rank: 10
XHE Sharpe Ratio Rank: 10
XHE Sortino Ratio Rank: 10
XHE Omega Ratio Rank: 10
XHE Calmar Ratio Rank: 10
XHE Martin Ratio Rank: 10

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. XHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and SPDR S&P Health Care Equipment ETF (XHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CNCR	XHE	Difference
Sharpe ratio: Return per unit of total volatility	—	0.12	—
Sortino ratio: Return per unit of downside risk	—	0.34	—
Omega ratio: Gain probability vs. loss probability	—	1.04	—
Calmar ratio: Return relative to maximum drawdown	—	0.15	—
Martin ratio: Return relative to average drawdown	—	0.32	—

Drawdowns

CNCR vs. XHE - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum XHE drawdown of -49.92%. Use the drawdown chart below to compare losses from any high point for CNCR and XHE.

Drawdown Indicators

	CNCR	XHE	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-49.92%	+49.92%
Max Drawdown (1Y) Largest decline over 1 year	—	-18.29%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-32.62%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-49.92%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-49.92%	—
Current Drawdown Current decline from peak	0.00%	-38.89%	+38.89%
Average Drawdown Average peak-to-trough decline	0.00%	-13.35%	+13.35%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	8.46%	—

Volatility

Volatility by Period

	CNCR	XHE	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	7.50%	—
Volatility (6M) Calculated over the trailing 6-month period	—	16.55%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	22.11%	-22.11%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	24.56%	-24.56%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	22.99%	-22.99%

CNCR vs. XHE - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than XHE's 0.35% expense ratio.

Dividends

CNCR vs. XHE - Dividend Comparison

CNCR has not paid dividends to shareholders, while XHE's dividend yield for the trailing twelve months is around 0.06%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
XHE SPDR S&P Health Care Equipment ETF	0.06%	0.08%	0.04%	0.03%	0.04%	0.00%	0.00%	0.05%	0.09%	0.78%	0.17%	7.22%

Frequently Asked Questions

Which ETF is better, CNCR or XHE?

On fees, XHE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or XHE?

XHE is cheaper with a 0.35% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, CNCR or XHE?

XHE has the higher dividend yield at 0.06%, compared with 0.00% for CNCR.

What is the main difference between CNCR and XHE?

CNCR tracks Loncar Cancer Immunotherapy Index, while XHE tracks S&P Health Care Equipment Select Industry Index. They also come from different issuers: Exchange Traded Concepts and State Street. Their fees differ too: 0.79% for CNCR and 0.35% for XHE.